Sitrin R G, Brubaker P G, Fantone J C
Am Rev Respir Dis. 1987 Apr;135(4):930-6. doi: 10.1164/arrd.1987.135.4.930.
Parenchymal fibrin deposition is well recognized in many forms of acute lung injury. Proteins derived from the actions of the coagulation and fibrinolytic systems may potentiate these inflammatory reactions as well as influence the subsequent repair process. However, the factors regulating fibrin formation and dissolution in acute pneumonitis have not been defined. In this study, we characterized the procoagulant (PC) and fibrinolytic activities simultaneously present in the alveolar space during the course of acute lung injury induced in rabbits by an intravenous injection of phorbol myristate acetate (PMA). Within 6 h of PMA injection, this injury was characterized histologically by extensive intra-alveolar fibrin formation and marked accumulation in pulmonary parenchyma of intravenously administered 125I-fibrinogen. Clearance of fibrin ensued over the remainder of the 72-h study period. Normal BAL fluid contained high levels of procoagulant activity which did not vary after the onset of inflammation. The procoagulant activity was attributed to particle-bound tissue thromboplastin as well as other factors of the extrinsic coagulation pathway. There were low levels of plasminogen activator (PA) activity in normal BAL fluid, but the mean activity increased 9.3-fold over control values by 12 h after PMA injection (p less than 0.01). When plasminogen activator activity in BAL fluid was referenced to the concomitant procoagulant activity, this ratio (PA/PC) increased 17.8-fold over controls, peaking 24 h after PMA injection (p less than 0.01). The levels of both procoagulant and plasminogen activator activities associated with alveolar macrophages were stable during the study period. Compared to alveolar macrophages, granulocytes expressed similar levels of plasminogen activator but negligible procoagulant activity.(ABSTRACT TRUNCATED AT 250 WORDS)
实质纤维蛋白沉积在多种急性肺损伤中已得到充分认识。凝血和纤维蛋白溶解系统作用产生的蛋白质可能会增强这些炎症反应,并影响后续的修复过程。然而,急性肺炎中调节纤维蛋白形成和溶解的因素尚未明确。在本研究中,我们对静脉注射佛波酯肉豆蔻酸酯(PMA)诱导兔急性肺损伤过程中肺泡腔内同时存在的促凝(PC)和纤维蛋白溶解活性进行了表征。在注射PMA后6小时内,这种损伤在组织学上的特征是肺泡内广泛形成纤维蛋白,并且静脉注射的125I-纤维蛋白原在肺实质中明显积聚。在72小时的研究期剩余时间内,纤维蛋白随之清除。正常支气管肺泡灌洗液(BAL液)含有高水平的促凝活性,炎症发生后该活性没有变化。促凝活性归因于颗粒结合的组织凝血活酶以及外源性凝血途径的其他因素。正常BAL液中纤溶酶原激活物(PA)活性水平较低,但在注射PMA后12小时,平均活性比对照值增加了9.3倍(p<0.01)。当BAL液中的纤溶酶原激活物活性与伴随的促凝活性相关联时,该比值(PA/PC)比对照增加了17.8倍,在注射PMA后24小时达到峰值(p<0.01)。在研究期间,与肺泡巨噬细胞相关的促凝和纤溶酶原激活物活性水平均保持稳定。与肺泡巨噬细胞相比,粒细胞表达的纤溶酶原激活物水平相似,但促凝活性可忽略不计。(摘要截断于250字)